膦酸,P,P'-[1-羟基-2-(3-吡啶基)亚乙基]双-钠盐 (1:1)（CAS 2673270-23-8）：分子式 C7H10NNaO7P2、分子量 305.09。
| CAS号 | 2673270-23-8 |
|---|---|
| 分子式 | C7H10NNaO7P2 |
| 分子量 | 305.09 |
| 应用领域 | Uses: For the treatment of Paget's disease of the bone (osteitis deformans)、postmenopausal and glucocorticoid-induced osteoporosis |
登记用途：Uses: For the treatment of Paget's disease of the bone (osteitis deformans)、postmenopausal and glucocorticoid-induced osteoporosis。
膦酸,P,P'-[1-羟基-2-(3-吡啶基)亚乙基]双-钠盐 (1:1) 是一种化工化合物，登记 CAS 号为 2673270-23-8，分子式 C7H10NNaO7P2（分子量 305.09）。
登记 CAS 号：2673270-23-8
其分子式 C7H10NNaO7P2 由 7 个碳、10 个氢、1 个氮、1 个钠、7 个氧、2 个磷 组成。
别名/同义词：膦酸,P,P'-[1-羟基-2-(3-吡啶基)亚乙基]双-钠盐 (1:1) · Phosphonic acid,P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis-, sodium salt (1:1)
膦酸,P,P'-[1-羟基-2-(3-吡啶基)亚乙基]双-钠盐 (1:1) 的 CAS 登记号为 2673270-23-8。
分子式 C7H10NNaO7P2，分子量 305.09。
别名/同义词：膦酸,P,P'-[1-羟基-2-(3-吡啶基)亚乙基]双-钠盐 (1:1)、Phosphonic acid,P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis-, sodium salt (1:1)。
登记用途：Uses: For the treatment of Paget's disease of the bone (osteitis deformans)、postmenopausal and glucocorticoid-induced osteoporosis。
膦酸,P,P'-[1-羟基-2-(3-吡啶基)亚乙基]双-钠盐 (1:1)（CAS 2673270-23-8）的独立参考数据，整理自公开化学数据库。
| CAS Registry Number | 2673270-23-8 |
|---|---|
| PubChem CID | 4194514 |
| Molecular formula | C7H10NNaO7P2 |
| IUPAC name | sodium hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinate |
| UNII (FDA) | OFG5EXG60L |
| Molecular Weight | 305.09 |
|---|---|
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 304.98301994 |
| Monoisotopic Mass | 304.98301994 |
| Topological Polar Surface Area | 151 |
| Heavy Atom Count | 18 |
Risedronate sodium; 115436-72-1; Actonel; Atelvia; Risedronate monosodium; Risedronic acid monosodium salt; OFG5EXG60L; risedronate sodium anhydrous; NE-58095 ANHYDROUS; NSC-722598; NSC-759280; Monosodium (1-hydroxy-2-(3-pyridinyl)ethylidene)bisphosphonate; Phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis-, monosodium salt; DTXCID9026132; NSC722598; Risendronate Sodium
| Reported hazard statements | H302, H312, H332 (86.4%), H362 (100%) |
|---|
H302+H312+H332 (86.4%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]
H302 (93.2%): Harmful if swallowed [Warning Acute toxicity, oral]
Phosphonic acid,P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis-, sodium salt (1:1) · CAS 2673270-23-8 · C7H10NNaO7P2. UNII OFG5EXG60L.
数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。
English page: Phosphonic acid,P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis-, sodium salt (1:1)